Tailored health literacy support for cancer patients
Tailored Health Literacy Follow-up in Cancer - the Tail HealthLit Cancer Trial
NA · Lovisenberg Diakonale Hospital · NCT05627180
This study tests whether personalized support from nurses can help cancer patients better understand their health information and improve their overall well-being.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 150 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Lovisenberg Diakonale Hospital (other) |
| Locations | 1 site (Oslo) |
| Trial ID | NCT05627180 on ClinicalTrials.gov |
What this trial studies
This project evaluates the impact of a health literacy intervention specifically designed for cancer patients. The intervention involves nurse-led follow-ups conducted through phone, digital, or in-person meetings, tailored to address individual health literacy needs. The primary goal is to enhance patients' health literacy, while secondary goals include improving quality of life, reducing symptom burden, enhancing self-management, and lowering healthcare costs. The study aims to provide personalized support to help patients navigate their health information and services more effectively.
Who should consider this trial
Good fit: Ideal candidates for this study are adults over 18 years old who have been diagnosed with cancer and are currently receiving treatment at the intervention hospital.
Not a fit: Patients who are not diagnosed with cancer or those who are under 18 years old will not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly improve cancer patients' ability to manage their health and enhance their overall quality of life.
How similar studies have performed: While the specific approach of tailored health literacy interventions in cancer care may be novel, similar studies focusing on health literacy have shown promising results in improving patient outcomes.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosed with cancer * Above 18 years old * Receiving treatment at the main intervention hospital Exclusion Criteria: * Not diagnosed with cancer * Not above 18 years old * Not in treatment at the intervention hospital
Where this trial is running
Oslo
- Lovisenberg Diakonale Hospital — Oslo, Norway (RECRUITING)
Study contacts
- Principal investigator: Christine R Borge, PhD — Lovisenberg Diaconal Hospital and University of Oslo
- Study coordinator: Christine R Borge, PhD
- Email: chrr@lds.no
- Phone: +47 23225000
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Cancer, Health literacy